| HOME >> MEDICINE >> TECHNOLOGY |
NEW YORK, Oct. 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Anti-CD20 Monoclonal Antibodies Industry
http://www.reportlinker.com/p0305155/Global-Anti-CD20-Monoclonal-Antibodies-Industry.html
This report analyzes the Global market for Anti-CD20 Monoclonal Antibodies in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 38 companies including many key and niche players such as Bayer Schering Pharma AG, Biocon, Biogen Idec, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Genmab A/S, GlaxoSmithKline Plc, GTC Biotherapeutics, Inc., Immunomedics, Inc., InNexus Biotechnology, Inc., LFB Group, Nycomed, Pfizer, Inc., Spectrum Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc., and UCB Pharmaceutical. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
ANTI-CD20 MONOCLONAL ANTIBODIES MCP-6217
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW II-1
Current and Future Analysis II-1
Monoclonal Antibody Market Garners Riches II-1
Rituxan/MabThera to Remain the Market Leader II-2
Rituxan's Success Spurs Development of New Anti-CD20 A
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |